300 related articles for article (PubMed ID: 29855355)
21. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
[TBL] [Abstract][Full Text] [Related]
22. Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011.
Graves PM; Makita L; Susapu M; Brady MA; Melrose W; Capuano C; Zhang Z; Dapeng L; Ozaki M; Reeve D; Ichimori K; Kazadi WM; Michna F; Bockarie MJ; Kelly-Hope LA
Parasit Vectors; 2013 Jan; 6():7. PubMed ID: 23311302
[TBL] [Abstract][Full Text] [Related]
23. Surveillance for lymphatic filariasis after stopping mass drug administration in endemic districts of Togo, 2010-2015.
Dorkenoo MA; Bronzan R; Yehadji D; Tchalim M; Yakpa K; Etassoli S; Adjeloh P; Maman I; Sodahlon Y
Parasit Vectors; 2018 Apr; 11(1):244. PubMed ID: 29661231
[TBL] [Abstract][Full Text] [Related]
24. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar.
Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Bradbury RS; McBride WJ
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006944. PubMed ID: 30419025
[TBL] [Abstract][Full Text] [Related]
26. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
27. Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis.
Maroto-Camino C; Hernandez-Pastor P; Awaca N; Safari L; Hemingway J; Massangaie M; Whitson D; Jeffery C; Valadez JJ
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007337. PubMed ID: 31276494
[TBL] [Abstract][Full Text] [Related]
28. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
[TBL] [Abstract][Full Text] [Related]
29. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
McLure A; Graves PM; Lau C; Shaw C; Glass K
Epidemics; 2022 Sep; 40():100591. PubMed ID: 35816826
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic Filariasis Elimination Status:
Matapo BB; Mpabalwani EM; Kaonga P; Simuunza MC; Bakyaita N; Masaninga F; Siyumbwa N; Siziya S; Shamilimo F; Muzongwe C; Mwase ET; Sikasunge CS
Trop Med Infect Dis; 2023 Jun; 8(7):. PubMed ID: 37505629
[TBL] [Abstract][Full Text] [Related]
31. Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration.
Derua YA; Kisinza WN; Simonsen PE
Parasit Vectors; 2018 Jul; 11(1):429. PubMed ID: 30029675
[TBL] [Abstract][Full Text] [Related]
32. Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.
Manyeh AK; Ibisomi L; Ramaswamy R; Baiden F; Chirwa T
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0007009. PubMed ID: 32804967
[TBL] [Abstract][Full Text] [Related]
33. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
[TBL] [Abstract][Full Text] [Related]
34. Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities.
Biritwum NK; Frempong KK; Verver S; Odoom S; Alomatu B; Asiedu O; Kontoroupis P; Yeboah A; Hervie ET; Marfo B; Boakye DA; de Vlas SJ; Gyapong JO; Stolk WA
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007115. PubMed ID: 31398203
[TBL] [Abstract][Full Text] [Related]
35. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
[TBL] [Abstract][Full Text] [Related]
36. Assessment of treatment impact on lymphatic filariasis in 13 districts of Benin: progress toward elimination in nine districts despite persistence of transmission in some areas.
Boko-Collins PM; Ogouyemi-Hounto A; Adjinacou-Badou EG; Gbaguidi-Saizonou L; Dossa NI; Dare A; Ibikounle M; Zoerhoff KL; Cohn DA; Batcho W
Parasit Vectors; 2019 May; 12(1):276. PubMed ID: 31146779
[TBL] [Abstract][Full Text] [Related]
37. Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(29):989-91. PubMed ID: 21796097
[TBL] [Abstract][Full Text] [Related]
38. Partnering for impact: Integrated transmission assessment surveys for lymphatic filariasis, soil transmitted helminths and malaria in Haiti.
Knipes AK; Lemoine JF; Monestime F; Fayette CR; Direny AN; Desir L; Beau de Rochars VE; Streit TG; Renneker K; Chu BK; Chang MA; Mace KE; Won KY; Lammie PJ
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005387. PubMed ID: 28207792
[TBL] [Abstract][Full Text] [Related]
39. Progress towards elimination of lymphatic filariasis in the Americas region.
Fontes G; da Rocha EMM; Scholte RGC; Nicholls RS
Int Health; 2020 Dec; 13(Suppl 1):S33-S38. PubMed ID: 33349876
[TBL] [Abstract][Full Text] [Related]
40. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
Fang Y; Zhang Y
Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
